Trial
NCT03342638
Maximizing Outcome of Multiple Sclerosis Transplantation
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Northwestern University
Collaborators
—
Condition
Multiple Sclerosis, Relapsing-Remitting
Intervention
Cyclophosphamide
Why stopped
PI Sabbatical
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-01-11